A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

Completed · Phase 1

Conditions studied: Heart Failure

In brief

The purpose of this clinical study is to estimate the safety and radiation dosimetry of a single dose of LMI1195 in healthy subjects and heart failure patients undergoing positron emission tomography (PET)

Key facts

Study ID

NCT00891241

Run by

Lantheus Medical Imaging

People needed

12

Starts

2009-08-01

Expected to finish

2009-11-01

Last updated by the study team

2020-11-16

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

• Hartford Hospital — Hartford, Connecticut, United States
• Yale University Medical Center — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.